These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 30542667)

  • 1. Randomized controlled trial evaluating the utility of urine HPV DNA for cervical cancer screening in a Pacific Island population.
    Hernandez BY; Tareg AC; Reichhardt M; Agapito A; Zhu X; Sy A; Yuji A; Killeen J; Chan O; Buenconsejo-Lum LE
    J Glob Health Rep; 2018; 2():. PubMed ID: 30542667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
    Sy AU; Hernandez BY; Tareg A; Reichhardt M; Buenconsejo-Lum L
    Cancer Epidemiol; 2017 Oct; 50(Pt B):283-288. PubMed ID: 29120838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples.
    Lim MC; Lee DH; Hwang SH; Hwang NR; Lee B; Shin HY; Jun JK; Yoo CW; Lee DO; Seo SS; Park SY; Joo J
    J Virol Methods; 2017 May; 243():74-79. PubMed ID: 28161277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
    Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
    [No Abstract]   [Full Text] [Related]  

  • 5. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test.
    Bernal S; Palomares JC; Artura A; Parra M; Cabezas JL; Robles A; Martín Mazuelos E
    J Clin Virol; 2014 Dec; 61(4):548-52. PubMed ID: 25453566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anal dysplasia screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and reliability of using a self-lavaging device for cytology and HPV testing for cervical cancer screening: findings from a pilot study.
    Jones HE; Mansukhani MM; Tong GX; Westhoff CL
    PLoS One; 2013; 8(12):e82115. PubMed ID: 24376516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
    Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
    BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia.
    Östensson E; Belkić K; Ramqvist T; Mints M; Andersson S
    Oncol Lett; 2021 Apr; 21(4):240. PubMed ID: 33664804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine-based human papillomavirus DNA testing as a screening tool for cervical cancer in high-risk women.
    Mendez K; Romaguera J; Ortiz AP; López M; Steinau M; Unger ER
    Int J Gynaecol Obstet; 2014 Feb; 124(2):151-5. PubMed ID: 24296266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
    Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
    J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
    Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
    J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Human Papillomavirus Detection in Urine and Cervical Samples Using High-Risk HPV DNA Testing in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Lekawanvijit S; Katruang N; Siriaunkgul S
    Obstet Gynecol Int; 2016; 2016():6801491. PubMed ID: 28101107
    [No Abstract]   [Full Text] [Related]  

  • 18. Acceptability and Concordance of Self- Versus Clinician- Sampling for HPV Testing among Rural South Indian Women.
    Madhivanan P; Nishimura H; Ravi K; Pope B; Coudray M; Arun A; Krupp K; Jayakrishna P; Srinivas V
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):971-976. PubMed ID: 33773563
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.